YEAR AFTER YEAR, Mary Bucklew strategized with a nurse practitioner about losing weight. "We tried exercise," like walking 35 ...

The global obesity care landscape is on the cusp of a major transformation. The year 2026 is expected to bring in the most powerful generation of anti-obesity medications ever developed. Building on ...

January 8, 2026 - By Amy Anderson - Adults aged 65 and older's desire to lose weight is frequently centered around improving functional ability and health outcomes, which may differ from those of ...

Washington often talks about lowering healthcare costs but ignores one of the simplest ways to do it: addressing the problem of obesity seriously. With the right tools, millions of Americans could ...

With access to unhealthy food soaring and physical activity levels declining, the World Obesity Federation predicts that between 2020 and 2035, Europe and Central Asia will experience a 61% increase ...

NEW DELHI – Obesity emerged as a central focus of public health policy in India in 2025, driven by a major overhaul of ...

With generic versions of the weight-loss drug Ozempic expected to hit the Canadian market this year, provincial data shows ...

India's third-largest drugmaker Cipla has made an early impact in the fast-expanding anti-obesity drug market, with its GLP-1 ...

Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...

From changing the definition to the rise of GLP-1 medications, and especially Prime Minister Narendra Modi’s clarion call against obesity ...

BioAge Labs is developing a promising weight management candidate. The medicine could have several advantages over approved anti-obesity drugs. However, BioAge is an early-stage biotech whose ...

Weight regain after discontinuation of tirzepatide was accompanied by a reversal of cardiometabolic improvements in a post-hoc analysis. For waist circumference, systolic blood pressure, and HbA1c ...